Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesLiabilities and Shareholders EquityNon-Current AssetsOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Pharma-Bio Serv (PBSV) Accounts Payables (2016 - 2026)

Pharma-Bio Serv (PBSV) has disclosed Accounts Payables for 15 consecutive years, with $991169.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Accounts Payables fell 12.1% year-over-year to $991169.0, compared with a TTM value of $991169.0 through Oct 2025, down 12.1%, and an annual FY2025 reading of $991169.0, down 12.1% over the prior year.
  • Accounts Payables was $991169.0 for Q4 2025 at Pharma-Bio Serv, up from $874379.0 in the prior quarter.
  • Across five years, Accounts Payables topped out at $2.1 million in Q4 2021 and bottomed at $874379.0 in Q3 2025.
  • Average Accounts Payables over 5 years is $1.4 million, with a median of $1.5 million recorded in 2022.
  • The sharpest move saw Accounts Payables soared 37.6% in 2021, then plummeted 33.78% in 2024.
  • Year by year, Accounts Payables stood at $2.1 million in 2021, then dropped by 22.0% to $1.6 million in 2022, then decreased by 9.95% to $1.5 million in 2023, then dropped by 23.15% to $1.1 million in 2024, then decreased by 12.1% to $991169.0 in 2025.
  • Business Quant data shows Accounts Payables for PBSV at $991169.0 in Q4 2025, $874379.0 in Q3 2025, and $937907.0 in Q2 2025.